Cargando…
Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis
BACKGROUND: IL-35 was recently identified as an anti-inflammatory cytokine. We previously reported that recombinant fusion protein of murine IL-35 and human IgG1 Fc fragment (rIL-35) reduced Th2 cytokines (IL-4 and IL-5) in vitro. However, it is unclear whether IL-35 can attenuate nasal allergic res...
Autores principales: | Suzuki, Motohiko, Yokota, Makoto, Nakamura, Yoshihisa, Ozaki, Shinya, Murakami, Shingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
, Japanese Society of Allergology. Production and hosting by Elsevier B.V.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130026/ https://www.ncbi.nlm.nih.gov/pubmed/27707583 http://dx.doi.org/10.1016/j.alit.2016.08.014 |
Ejemplares similares
-
Intranasal administration of regulatory dendritic cells is useful for the induction of nasal mucosal tolerance in a mice model of allergic rhinitis
por: Suzuki, Motohiko, et al.
Publicado: (2020) -
Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008) -
Repair of Orbital Floor Fracture With Modified Transnasal Endoscopic Approach Through Anterior Space to Nasolacrimal Duct
por: Suzuki, Motohiko, et al.
Publicado: (2017) -
Evaluating the Safety of Intranasal Steroids in the Treatment of Allergic Rhinitis
por: Sheth, Ketan
Publicado: (2008) -
Novel mouse model of steroid-resistant allergic rhinitis by repeated intranasal administration of OVA
por: Izumi, Kazunari, et al.
Publicado: (2015)